Luxembourg hosts international flagship cancer epidemiology conference
12 May 2021
Bringing together about 150 international scientists, clinicians, healthcare professionals and policymakers from 17 nations, the 45th edition of the Group of Cancer Epidemiology and Registration in Latin Language Countries (GRELL) conference takes place in Luxembourg in a fully virtual format.
Organised in Luxembourg for the first time by the National Cancer Registry of Luxembourg (RNC) at the Luxembourg Institute of Health (LIH), the meeting features several prominent speakers, providing an opportunity to discuss the latest developments in the field of
cancer epidemiology with a particular focus on COVID-19 and cancer, as well as childhood and adolescent cancers.
National and international prominent speakers in Luxembourg
The three-day event gathers prominent speakers, who are addressing some of the key clinical challenges related to cancer.
Some of the national and international speakers and moderators include:
- Dr Carole Bauer, Fondation Cancer Luxembourg
- Prof Gilbert Massard, University of Luxembourg
- Dr Sophie Couffignal, Head of the LIH Public Health Expertise unit and Operational Director of the Luxembourg National Cancer Registry
- Dr Guy Berchem, Associated Medical Director at LIH and President of the National Cancer Institute of Luxembourg
- Dr Claudine Backes, Epidemiologist for the Luxembourg National Cancer Registry at LIH
- Prof Michel Mittelbronn from the Laboratoire National de Santé (LNS)
- Anne Goeres, Director of the Fondatioun Kriibskrank Kanner
- Dr Eva Steliarova-Foucher, International Agency for Research on Cancer, France
- Prof Kathy Pritchard-Jones, International Society of Paediatric Oncology & University College London, UK
The association aims to coordinate the activities of the “Group for Epidemiology and Cancer Registry in Latin Laguage Coutries” (GRELL), gathered since 1976.
GRELL promotes epidemiological cancer research, mainly through the registration of cases in geographically defined populations.
Visit Luxembourg Institute of Health to know more.
In conversation with our young researchers: Agnieszka DemczukHow can we improve allergen-specific immunotherapy to better respond to allergic diseases? Agnieszka Demczuk is a PhD candidate in the…
SciLux podcast – Ibrahim Boussaad, research scientist at LCSBHow to identify key mechanism of Parkinson’s disease? Parkinson’s disease is a neurodegenerative disease that we are not able to…
In conversation with our young researchers: Charlotte StoffelsHow can we better understand potential negative impacts of PFAS on our health? Charlotte Stoffels is a PhD candidate in…
SciLux podcast – Camille Perchoux, research associate at LISERHow urban environments impact health? Characteristics where we live or where we travel on a daily basis have an influence…
A pioneering study using vocal biomarkers to monitor COVID-19The Predi-COVID Cohort study, a project led by Dr Guy Fagherazzi of the Luxembourg Institute of Health (LIH), showed for…
In conversation with our young researchers: Magretta AdiamahHow RNA modifications are involved in cancer-related processes and how they affect tumour behaviour? Magretta Adiamah is a postdoctoral fellow…
In conversation with our young researchers: Marion TharreyHow does one utilize methods from epidemiology, public health intervention research and health geography to study the economic, social, environmental…
OECD Report – Evaluation of Luxembourg’s response to the COVID-19 pandemicIn a report presented on the 5th of October 2022, the OECD analyses Luxembourg’s response to the COVID-19 pandemic. The…